Tag: Forecast
Latest article
Section III Trial Reveals Lilly’s Tirzepatide is Superior to Rival in Kind 2 Diabetes
Jonathan Weiss / Shutterstock
Eli Lillys The Phase III SURPASS 2 clinical trial shows treatment with tirzepatide, a once-weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like...
Mohawk Group Accelerates Accretive M&A Technique Saying Acquisition of Main E-Commerce Important Oils and...
The company increases its net sales margin to $ 340 million - $ 370 million for 2021 Offers 2021 net income outlook range...